EUVIMEDEUVIMED entdecken
Open Access

Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data

Ryo Emoto iD, Kiyoaki Ishii, Toshinari Takamura, Shigeyuki Matsui

Statistics in Medicine · 2026-07 · 45 (15-17)

DOI: 10.1002/sim.70651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 15.07.2026. Verfasst von Ryo Emoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Data Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in biotechnology and personalized medicine have driven the development of efficient clinical trial methodologies for assessing treatment efficacy across multiple populations defined by treatment effect modifiers. Within‐patient comparison of different treatments is a promising approach for improving study efficiency across multiple populations by eliminating between‐patient variability in treatment evaluation. This study provides a framework for evaluating treatment efficacy in multiple populations for crossover trials and evaluates the efficacy gain in comparison with the standard parallel‐group analysis. Simulation experiments confirm that the crossover analysis consistently outperforms the parallel‐group analysis in statistical power, especially when carryover effects are small. An application to a clinical trial in Type 2 diabetes demonstrates the efficiency advantages of the crossover analysis. These numerical results emphasize the potential of the crossover analysis for enhancing the efficiency of clinical development of personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHumansCross-Over StudiesPrecision MedicineDiabetes Mellitus, Type 2Treatment Effect HeterogeneityComputer SimulationTreatment OutcomeModels, StatisticalSample Size

Stichwörter der Autor:innen

crossover trialspersonalized medicinerequired sample sizestatistical powertreatment effect heterogeneity

Autor:innen und Institutionen

  • Department of Biostatistics and Data Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Endocrinology and Metabolism, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Musculoskeletal Disease, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Department of Interdisciplinary Statistical Mathematics, The Institute of Statistical Mathematics, Tokyo, Japan.

ORCID-Profile: Ryo Emoto

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Emoto, R., Ishii, K., Takamura, T., & Matsui, S. (2026). Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data. Statistics in Medicine, 45(15-17). https://doi.org/10.1002/sim.70651

Vancouver

Emoto R, Ishii K, Takamura T, Matsui S. Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data. Statistics in Medicine. 2026;45(15-17). doi:10.1002/sim.70651

BibTeX
@article{Emoto2026,
  author = {Emoto, Ryo and Ishii, Kiyoaki and Takamura, Toshinari and Matsui, Shigeyuki},
  title = {Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {15-17},
  doi = {10.1002/sim.70651}
}
Kostenlos starten →